Largest biotech by total liabilities

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Amgen leads the 24 biotech ranked by total liabilities, at A$121.7B, ahead of Gilead Sciences (A$54.1B) and Biogen (A$16.6B). Figures as of 18 Nov 2026, 14:30 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenA$121.7B
Median
A$1B
Combined market value
A$1.26T
Countries
5

Market values as of .

Largest biotech by total liabilities
#CompanyTotal liabilities ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareA$121.7BA$364.5BA$673.94 0.96% down 34% up United States
2Gilead SciencesGILD · Health CareA$54.1BA$313.8BA$253.01 1.60% up 33% up United States
3BiogenBIIB · Health CareA$16.6BA$55.1BA$372.67 0.34% down 49% up United States
4ModernaMRNA · Health CareA$5.5BA$125.1BA$309.09 0.58% up 755% up United States
5BioNTechBNTX · Health CareA$4.6BA$31.3BA$126.10 0.47% down 16% down Germany
6QiagenQGEN · Health CareA$3.7BA$15.2BA$73.82 0.14% down 12% up Netherlands
7Halozyme TherapeuticsHALO · Health CareA$3.7BA$16.3BA$142.61 0.55% down 37% up United States
8Neurocrine BiosciencesNBIX · Health CareA$2BA$25BA$246.56 0.37% up 20% up United States
9argenxARGX · Health CareA$2BA$88.5BA$1,408.01 0.36% down 4% up Belgium
10ImmunityBioIBRX · Health CareA$1.5BA$9.9BA$9.28 0.20% down 193% up United States
11RepligenRGEN · Health CareA$1.3BA$15.4BA$241.00 0.37% down 5% up United States
12Revolution MedicinesRVMD · Health CareA$1.1BA$52.3BA$241.76 2.50% down 131% up United States
13ExelixisEXEL · Health CareA$1BA$24.7BA$101.17 0.61% down 63% up United States
14Bio-TechneTECH · Health CareA$711.1MA$17BA$107.93 0.22% down 26% up United States
15CRISPR TherapeuticsCRSP · Health CareA$510.3MA$5.8BA$59.66 0.54% down 21% down Switzerland
16VaxcytePCVX · Health CareA$471.4MA$14BA$88.27 3.59% down 22% up United States
17Adaptive BiotechnologiesADPT · Health CareA$427.6MA$6.6BA$41.04 3.05% down 88% up United States
18Kodiak SciencesKOD · Health CareA$288.5MA$9.4BA$143.84 3.90% down 396% up United States
19Twist BioscienceTWST · Health CareA$251MA$11.3BA$166.43 6.63% up 340% up United States
20Kymera TherapeuticsKYMR · Health CareA$242.4MA$15.4BA$180.58 3.44% down 87% up United States
21Scholar Rock HoldingSRRK · Health CareA$236MA$8.2BA$66.99 1.21% up 14% up United States
22Krystal BiotechKRYS · Health CareA$169.8MA$13.1BA$442.23 0.32% down 46% up United States
23ImmunovantIMVT · Health CareA$155.2MA$10.2BA$49.35 0.21% down 43% up United States
24CG OncologyCGON · Health CareA$57.9MA$10.5BA$117.30 6.89% down 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 1.4860 AUD).

Questions and answers

Which biotech rank first by total liabilities?

Amgen (A$121.7B), Gilead Sciences (A$54.1B) and Biogen (A$16.6B) are the top three of the 24 biotech ranked by total liabilities as of 18 Nov 2026, 14:30 UTC.

How many biotech are in this ranking?

24 are ranked by total liabilities.

What are these biotech worth together?

The 24 biotech ranked by total liabilities have a combined market value of A$1.26T as of 18 Nov 2026, 14:30 UTC.

What does ranking by total liabilities measure?

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest biotech by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-liabilities

Underlying data: Yahoo Finance; SEC EDGAR.